In an experimental DCM model, metformin suppressed the expression of COL-I, III, TGF-β, CTGF, ICAM and VCAM genes, reduced collagen deposition and improved cardiac function by reversing DCM-associated damage [255]. Here, CCN2 is linked to familial dilated cardiomyopathy.